Early Recurrences During The Blanking Period After Atrial Fibrillation Ablation

Liang, Jackson J.

doi:10.4022/jafib.1726

Cited by 20 publications

(12 citation statements)

References 41 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In agreement with other studies, we found that early recurrence was a strong predictor for recurrence during the later months . Therefore, detection of early recurrence has clinical prognostic value and could aid in tailoring treatment plans and determining when an ablation should be considered successful, or if repeat ablation and continued anticoagulation is required.…”

Section: Discussionsupporting

confidence: 91%

“…Early reablation has been shown to improve long-term freedom from AF. 23,26,27 In agreement with other studies, 28 we found that early recurrence was a strong predictor for recurrence during the later months. 23 Mobile heart monitor devices may be useful not only for their positive predictive value but also for their ability to eliminate false positives.…”

Section: Discussionsupporting

confidence: 91%

“…23,26,27 In agreement with other studies, 28 we found that early recurrence was a strong predictor for recurrence during the later months. 23 Mobile heart monitor devices may be useful not only for their positive predictive value but also for their ability to eliminate false positives. In this study, we were not able to assess how many patients believed they were in AF, but discovered that they were in sinus rhythm using the device.…”

Section: Discussionsupporting

confidence: 91%

“…In a secondary analysis for patients who underwent RFA procedures at enrollment, early and late recurrences were differentiated to account for arrhythmias that take place during the healing process as a result of inflammation and edema, which usually resolve within a few weeks . While detection of recurrence in the intervention group was greater after the first month, too few patients had recurrences during the latter 5 months for the differences to be significant.…”

Section: Discussionmentioning

confidence: 99%

“…The Heart Rhythm Society, the European Heart Rhythm Association, and the European Cardiac Arrhythmia Society recommend a 3‐month blanking period, but there is debate on the usefulness of blanking periods, as recurrence within the first month is a strong predictor of later recurrence. Early reablation has been shown to improve long‐term freedom from AF …”

Section: Discussionmentioning

confidence: 99%

See 4 more Smart Citations

Recurrent atrial fibrillation/flutter detection after ablation or cardioversion using the AliveCor KardiaMobile device: iHEART results

Goldenthal

Sciacca

Riga

et al. 2019

Cardiovasc electrophysiol

View full text Add to dashboard Cite

Objective: This study evaluated the impact of daily ECG self-recordings on time to documented recurrent atrial fibrillation (AF) or atrial flutter (AFL) and time to treatment of recurrent arrhythmia in patients undergoing catheter radiofrequency ablation (RFA) or direct current cardioversion (DCCV) for AF/AFL. Background: AF recurrence rates after RFA and DCCV are 20–45% and 60–80% respectively. Randomized trials comparing mobile ECG devices to standard of care have not been performed in an AF/AFL population after treatment. Methods: Of 262 patients consented, 238 were randomized to either standard of care (123) or to receive the iHEART intervention (115). Patients in the intervention group were provided with and trained to use an AliveCor® KardiaMobile ECG monitor, and were instructed to take and transmit daily ECG recordings. Data were collected from transmitted ECG recordings and patients’ electronic health records. Results: In a multivariate Cox model, the likelihood of recurrence detection was greater in the intervention group (hazard ratio = 1.56, 95% CI: 1.06–2.30, p = .024). Hazard ratios did not differ significantly for RFA and DCCV procedures. Recurrence during the first month after ablation strongly predicted later recurrence (hazard ratio = 4.53, 95% CI: 2.05–10.00, p = .0006). Time to from detection to treatment was shorter for the control group. (hazard ratio = 0.33, 95% CI: 0.57–2.92, p <.0001) Conclusions: The use of mobile ECG self-recording devices allows for earlier detection of AF/AFL recurrence and may empower patients to engage in shared health decision making.

show abstract

Section: Discussionsupporting

confidence: 91%

Section: Discussionsupporting

confidence: 91%

Section: Discussionsupporting

confidence: 91%

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

See 3 more Smart Citations

Recurrent atrial fibrillation/flutter detection after ablation or cardioversion using the AliveCor KardiaMobile device: iHEART results

Goldenthal

Sciacca

Riga

et al. 2019

Cardiovasc electrophysiol

View full text Add to dashboard Cite

show abstract

Diagnosing a wide complex tachycardia using basic electrophysiologic properties of the cardiac conduction system

Siroky

Mehta

2021

Journal of Arrhythmia

View full text Add to dashboard Cite

show abstract

Interplay between natriuretic peptides and left atrial mechanics and the relation to recurrence of atrial fibrillation following catheter ablation

Olsen

Darkner

Goetze

et al. 2023

Int J Cardiovasc Imaging

View full text Add to dashboard Cite

The relationship between natriuretic peptides and atrial distension is not fully understood. We sought to examine their interrelationship and how they relate to atrial fibrillation (AF) recurrence following catheter ablation. We analyzed patients enrolled in the AMIO-CAT trial (amiodarone vs. placebo for reducing AF recurrence). Echocardiography and natriuretic peptides were assessed at baseline. Natriuretic peptides included mid-regional proANP (MR-proANP) and N-terminal proBNP (NT-proBNP). Atrial distension was assessed by left atrial strain measured by echocardiography. The endpoint was AF recurrence within 6 months after a 3-month blanking period. Logistic regression was used to assess the association between log-transformed natriuretic peptides and AF. Multivariable adjustments were made for age, gender, randomization, and left ventricular ejection fraction. Of 99 patients, 44 developed AF recurrence. No differences in natriuretic peptides nor echocardiography were observed between the outcome groups. In unadjusted analyses, neither MR-proANP nor NT-proBNP were significantly associated with AF recurrence [MR-proANP: OR = 1.06 (0.99–1.14), per 10% increase; NT-proBNP: OR = 1.01 (0.98–1.05), per 10% increase]. These findings were consistent after multivariable adjustments. However, atrial strain significantly modified the association between MR-proANP and AF (p for interaction = 0.009) such that MR-proANP was associated with AF in patients with high atrial strain [OR = 1.24 (1.06–1.46), p = 0.008, per 10% increase] but not in patients with low atrial strain. In patients with high atrial strain, an MR-proANP > 116 pmol/L posed a fivefold higher risk of AF recurrence [HR = 5.38 (2.19–13.22)]. Atrial natriuretic peptide predicts AF recurrence in patients with preserved atrial distension. Assessing atrial strain may assist the interpretation of natriuretic peptides. Graphical abstract

show abstract

Early Recurrences During The Blanking Period After Atrial Fibrillation Ablation

Cited by 20 publications

References 41 publications

Recurrent atrial fibrillation/flutter detection after ablation or cardioversion using the AliveCor KardiaMobile device: iHEART results

Recurrent atrial fibrillation/flutter detection after ablation or cardioversion using the AliveCor KardiaMobile device: iHEART results

Diagnosing a wide complex tachycardia using basic electrophysiologic properties of the cardiac conduction system

Interplay between natriuretic peptides and left atrial mechanics and the relation to recurrence of atrial fibrillation following catheter ablation

Contact Info

Product

Resources

About